Viro Consult’s Post

ReciPredict- Value By Design In our latest interview series Dr. Uwe Hanenberg, Head of Product Implementation at Recipharm explains the unique capabilities of ReciPredict. What sets it apart? It brings a comprehensive suite of tools into one cohesive platform. With ReciPredict we have the resources to fully characterize your material, assessing attributes like flowability, particle size, density, and other essential factors. Additionally, ReciPredict includes essential software and statistical tools, enabling precise analysis and the extraction of meaningful insights from this data. But the strength lies not just in technology—it’s also about the scientific experts at Recipharm. We understand your product’s complexities, and by harnessing our approach and expertise, we provide the clarity you need to take the next steps toward success. Learn more about ReciPredict : https://lnkd.in/dHyEyaUi #QbD #Drugdevelopment #TechTransfer #OSD

Great hearing Uwe give a more in-dept explanation on what sets ReciPredict apart

Roysis and Our Commitment to Excellence as Proud FİNAT Members At Roysis, we are always striving for the best when it comes to label and barcode systems, and our membership with FİNAT is a testament to that commitment. For those who aren’t familiar, FİNAT is the European association for the self-adhesive label industry. It connects companies from all around the world, providing insight, networking, and top-tier innovation to help businesses stay ahead in the ever-evolving label industry. As a member of FİNAT, Roysis is part of a global community that focuses on pushing the boundaries of labeling technology and promoting sustainability, quality, and creativity. This collaboration opens the door to exciting opportunities for us, allowing us to stay at the cutting edge of industry standards and bring the very best to our clients. Why FİNAT Membership Matters Global Networking: Being a FİNAT member allows us to connect with international experts and leaders in the label industry, ensuring that we stay informed on global trends and innovations. Access to Knowledge: With FİNAT, we have access to valuable resources like industry reports, technological advancements, and sustainability practices that help us improve our product offerings. Commitment to Sustainability: FİNAT actively promotes sustainable practices in label manufacturing, which aligns with our dedication to producing eco-friendly solutions. Innovation: Staying ahead in a competitive market is key, and FİNAT keeps us updated on the latest innovations in labeling, helping us deliver unique and cutting-edge solutions to our clients. What This Means for Our Clients Our partnership with FİNAT directly benefits our clients. With access to the latest trends and technologies, Roysis can offer even more customized and innovative solutions, ensuring that your labeling needs are met with precision, creativity, and reliability. At Roysis, we’re always pushing the envelope, and with FİNAT’s support, we continue to grow and innovate in ways that truly make a difference. Let us show you the Roysis difference—where quality meets innovation. 🚀✨ #LabelIndustry #FİNAT #Innovation #Sustainability #RoysisLabels #LabelingSolutions #BarcodeSystems #GlobalNetworking #PackagingInnovation #SelfAdhesiveLabels #SustainablePackaging #QualityAndInnovation #IndustryLeaders

✨ 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐧𝐠 𝐨𝐧 𝐚𝐧 𝐈𝐧𝐜𝐫𝐞𝐝𝐢𝐛𝐥𝐞 2024 𝐚𝐭 𝐍𝐈𝐑𝐋𝐀𝐁 ✨ As we close out 2024, the NIRLAB team takes a moment to reflect on the incredible progress and impact we’ve achieved this year. 🚀 ✅ 𝐓𝐡𝐨𝐮𝐬𝐚𝐧𝐝𝐬 𝐨𝐟 𝐬𝐜𝐚𝐧𝐬 𝐩𝐞𝐫 𝐝𝐚𝐲 were performed, empowering businesses worldwide to make faster, data-driven decisions when they matter most. 🌍 Our solutions reached 53 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬, a clear testament to solving global challenges across industries. 🤝 This year, we also 𝐬𝐢𝐠𝐧𝐞𝐝 𝐚𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐦𝐨𝐫𝐞 𝐭𝐡𝐚𝐧 40 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐨𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐢𝐧𝐠 60+ 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬, reflecting the growing global interest in what we do and the trust in NIRLAB’s solutions. 📈 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐦𝐞𝐧𝐭𝐬 marked the year, including: • New applications like 𝐥𝐢𝐯𝐞 𝐬𝐚𝐥𝐦𝐨𝐧 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐜𝐨𝐮𝐧𝐭𝐞𝐫𝐟𝐞𝐢𝐭 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧, and 𝐟𝐞𝐞𝐝 𝐬𝐜𝐚𝐧𝐧𝐢𝐧𝐠. • Substantial enhancements to our 𝐜𝐚𝐧𝐧𝐚𝐛𝐢𝐬 and 𝐧𝐚𝐫𝐜𝐨𝐭𝐢𝐜𝐬 𝐝𝐚𝐭𝐚𝐛𝐚𝐬𝐞𝐬, ensuring unmatched precision and reliability. None of this would have been possible without: ✨ The unwavering 𝐝𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦, ✨ The 𝐭𝐫𝐮𝐬𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬, and ✨ The ongoing 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬. We extend our deepest gratitude to all of you for being part of NIRLAB’s journey and vision. 🔮 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐚𝐡𝐞𝐚𝐝 𝐭𝐨 2025: • We are 𝐝𝐨𝐮𝐛𝐥𝐢𝐧𝐠 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 to fuel innovation. • Expanding our 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐫𝐞𝐬𝐞𝐧𝐜𝐞 further. • Launching 𝐧𝐞𝐰 𝐮𝐬𝐞𝐫-𝐟𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐬 to drive greater impact across industries like healthcare, pharma, food, feed, agriculture, polymers, pharmaceuticals, and more. Wishing you all a 𝐩𝐫𝐨𝐬𝐩𝐞𝐫𝐨𝐮𝐬 𝐚𝐧𝐝 𝐬𝐮𝐜𝐜𝐞𝐬𝐬𝐟𝐮𝐥 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫! 🥂 Here’s to enabling informed decisions on the spot and a year filled with growth and innovation. 🎉 𝐌𝐞𝐫𝐫𝐲 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐍𝐈𝐑𝐋𝐀𝐁 𝐭𝐞𝐚𝐦! 🎉 #NIRLAB #YearInReview #Innovation #Gratitude #NewYear2025 #GlobalImpact #DataDrivenDecisions Florentin Coppey Matteo Delbrück

🗞️The April issue of the Meditrial newsletter is out and spotlights a must-read article on HEU-EFS! 🌟Don’t miss out on the insightful perspectives from Monica Tocchi, MD, PhD, Founder and CMO of Meditrial, on #EFS 👇Read the newsletter below!👇 https://lnkd.in/eQgPrQ3Z

As a frontrunner in laboratory informatics solutions, we, Agaram Technologies, are proud to announce our collaboration with Global Value Web. Renowned for their expertise in the field of reliable and accessible data, we aim to serve the scientific needs of the European community with specialized solutions. GVW will be our exclusive reseller in Ireland, Germany, Denmark, Norway, Sweden, Finland, Estonia, Latvia, Lithuania, Poland, Czechia, Slovakia, Austria, Hungary and non-exclusively in India and United Kingdom. Together, Agaram Technologies and GVW will empower clients to achieve operational excellence, regulatory compliance, competitive advantage, and lab automation in an increasingly digital and interconnected world by collaborating our resources, expertise, and vision. Learn more about our shared vision ahead. Read the complete blog here: https://bit.ly/4cMOe53 Stay tuned as we start this journey towards reaching new goals and developing impactful solutions to accelerate scientific advancements. #StrategicPartnership #WorkingTogether #Laboratories #GlobalPartnership #ScientificAdvancements #Innovation #AgaramTechnologies

Cost-Effective Solutions for Medication Adherence in Clinical Trials   There is a significant concern regarding the cost prohibitive nature of many current medication adherence solutions available in clinical trials. As you are aware, maintaining adherence is critical for the success of these trials. However, the high costs associated with these solutions often pose a substantial burden. Fortunately, there are innovative medication adherence solutions available that can ease these financial constraints. Implementing these alternatives can significantly reduce costs while ensuring that patient compliance is significant, and the data analysis is more comprehensive. As is often said, "the juice is worth the squeeze"!    #medicationadherencesolutions #medicationadherencemeasurement #patientadherence #patientnon-adherence

We are focused on becoming the leading treatment for osteoarthritis in both humans and animals over the next five years

Thank you LSX Nordic Congress for hosting a great congress bringing founders, operators and investors together to discuss #Healthcare & #LifeScience opportunities and challenges. I had the pleasure to participate in an intriguing panel discussion with Ed Pease, Pekka Simula, Henrik Cullen and Virpi Muhonen that was excellently moderated by Claudia Colciago.  We addressed some of my favorites topics such as:  ➡ How do you navigate growth expectations from VC’s in a European market that is 70-80% publicly funded and typically present regulatory, reimbursement or infrastructure growth blockers? ➡ If you cracked the EU market are you ready to conquer the US … and vice versa?  ➡ Can your GTM plan across public & private payers, D2C, B2B and geographical markets address investor expectations? ➡ When is VC funding right and when are alternative funding models better suited? 

The LabTalk-Experts Program brings together distinguished private chain lab guests worldwide to share their experiences and ideas, uniting voices for better healthcare. Watch the upcoming LabTalk-Experts video series, beginning with Prof. Dr. Iman Shaheen and Dr. Bashar Karimi. Stay tuned for more insights on this program. #MindrayIVD #ChainLaboratory #LabTalk #EmpoweringTrust